Absence of the GPR37/PAEL receptor impairs striatal Akt and ERK2 phosphorylation, ΔFosB expression, and conditioned place preference to amphetamine and cocaine

FASEB Journal

Volumn 25, Issue 6, 2011, Pages 2071-2081

  Marazziti, Daniela ^a   Di Pietro, Chiara ^a   Mandillo, Silvia ^a   Golini, Elisabetta ^a   Matteoni, Rafaele ^a   Tocchini Valentini, Glauco P ^a  

^a CNR   (Italy)

Author keywords

Cellular signaling pathways; D1 receptor; D2 receptor; DA; DAT

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 37; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; TRANSCRIPTION FACTOR DELTA FOSB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG DEPENDENCE; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRIATE CORTEX;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, G-PROTEIN-COUPLED;

ANIMALIA; MUS;

EID: 79957915692     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-175737     Document Type: Article

References (63)

1. Marazziti, D., Golini, E., Gallo, A., Lombardi, M. S., Matteoni, R., and Tocchini-Valentini, G. P. (1997) Cloning of GPR37, a gene located on chromosome 7 encoding a putative G-protein-coupled peptide receptor, from a human frontal brain EST library. Genomics 45, 68-77 (Pubitemid 27449385)
2. Marazziti, D., Gallo, A., Golini, E., Matteoni, R., and Tocchini-Valentini, G. P. (1998) Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G protein-coupled peptide receptor expressed in brain and testis. Genomics 53, 315-324 (Pubitemid 28527634)
3. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., and Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902 (Pubitemid 32635090)
4. Marazziti, D., Golini, E., Mandillo, S., Magrelli, A., Witke, W., Matteoni, R., and Tocchini-Valentini, G. P. (2004) Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. Proc. Natl. Acad. Sci. U. S. A. 101, 10189-10194 (Pubitemid 38891217)
5. Marazziti, D., Mandillo, S., Di Pietro, C., Golini, E., Matteoni, R., and Tocchini-Valentini, G. P. (2007) GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs. Proc. Natl. Acad. Sci. U. S. A. 104, 9846-9851 (Pubitemid 47175354)
6. Greengard, P. (2001) The neurobiology of slow synaptic transmission. Science 294, 1024-1030
7. Gainetdinov, R. R., and Caron, M. G. (2003) Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43, 261-284
8. Carlsson, A. (2001) A paradigm shift in brain research. Science 294, 1021-1024
9. Gainetdinov, R. R., Sotnikova, T. D., and Caron, M. G. (2002) Monoamine transporter pharmacology and mutant mice. Trends Pharmacol. Sci. 23, 367-373
10. Bozzi, Y., and Borrelli, E. (2006) Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? Trends Neurosci. 29, 167-174
11. Kebabian, J. W., and Calne, D. B. (1979) Multiple receptors for dopamine. Nature 277, 93-96
12. Beaulieu, J. M., Tirotta, E., Sotnikova, T. D., Masri, B., Salahpour, A., Gainetdinov, R. R., Borrelli, E., and Caron, M. G. (2007) Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J. Neurosci. 27, 881-885
13. Beaulieu, J. M., Sotnikova, T. D., Yao, W. D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., and Caron, M. G. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. U. S. A. 101, 5099-5104
14. Beaulieu, J. M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., and Caron, M. G. (2005) An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261-273
15. Zhang, L., Lou, D., Jiao, H., Zhang, D., Wang, X., Xia, Y., Zhang, J., and Xu, M. (2004) Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J. Neurosci. 24, 3344-3354 (Pubitemid 38451900)
16. Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J. C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., Greengard, P., Herve, D., and Girault, J. A. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U. S. A. 102, 491-496
17. Chen, J., Rusnak, M., Luedtke, R. R., and Sidhu, A. (2004) D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J. Biol. Chem. 279, 39317-39330 (Pubitemid 39258194)
18. Wang, C., Buck, D. C., Yang, R., Macey, T. A., and Neve, K. A. (2005) Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. J. Neurochem. 93, 899-909
19. Berhow, M. T., Hiroi, N., and Nestler, E. J. (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715 (Pubitemid 26251066)
20. Shi, X., and McGinty, J. F. (2007) Repeated amphetamine treatment increases phosphorylation of extracellular signal-regulated kinase, protein kinase B, and cyclase response element-binding protein in the rat striatum. J. Neurochem. 103, 706-713
21. Beaulieu, J. M., Gainetdinov, R. R., and Caron, M. G. (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu. Rev. Pharmacol. Toxicol. 49, 327-347
22. Masson, J., Sagne, C., Hamon, M., and El Mestikawy, S. (1999) Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51, 439-464 (Pubitemid 29420211)
23. Torres, G. E., Gainetdinov, R. R., and Caron, M. G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 13-25
24. Valjent, E., Pages, C., Herve, D., Girault, J. A., and Caboche, J. (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur. J. Neurosci. 19, 1826-1836 (Pubitemid 38482570)
25. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., and Caron, M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612
26. Salahpour, A., Ramsey, A. J., Medvedev, I. O., Kile, B., Sotnikova, T. D., Holmstrand, E., Ghisi, V., Nicholls, P. J., Wong, L., Murphy, K., Sesack, S. R., Wightman, R. M., Gainetdinov, R. R., and Caron, M. G. (2008) Increased amphetamine-induced hyperactivity and reward in mice over-expressing the dopamine transporter. Proc. Natl. Acad. Sci. U. S. A. 105, 4405-4410
27. Giros, B., and Caron, M. G. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49
28. Uhl, G. R., Vandenbergh, D. J., and Miner, L. L. (1996) Knockout mice and dirty drugs. Drug addiction. Curr. Biol. 6, 935-936
29. Hiroi, N., Brown, J. R., Haile, C. N., Ye, H., Greenberg, M. E., and Nestler, E. J. (1997) FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc. Natl. Acad. Sci. U. S. A. 94, 10397-10402 (Pubitemid 27407053)
30. Graybiel, A. M., Moratalla, R., and Robertson, H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U. S. A. 87, 6912-6916
31. Nguyen, T. V., Kosofsky, B. E., Birnbaum, R., Cohen, B. M., and Hyman, S. E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U. S. A. 89, 4270-4274
32. Nestler, E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128
33. Hope, B., Kosofsky, B., Hyman, S. E., and Nestler, E. J. (1992) Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. U. S. A. 89, 5764-5768
34. Pich, E. M., Pagliusi, S. R., Tessari, M., Talabot-Ayer, D., Hooft van Huijsduijnen, R., and Chiamulera, C. (1997) Common neural substrates for the addictive properties of nicotine and cocaine. Science 275, 83-86 (Pubitemid 27020313)
35. Hope, B. T., Nye, H. E., Kelz, M. B., Self, D. W., Iadarola, M. J., Nakabeppu, Y., Duman, R. S., and Nestler, E. J. (1994) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13, 1235-1244 (Pubitemid 24372141)
36. Nye, H. E., Hope, B. T., Kelz, M. B., Iadarola, M., and Nestler, E. J. (1995) Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275, 1671-1680 (Pubitemid 26129960)
37. Nestler, E. J., Barrot, M., and Self, D. W. (2001) DeltaFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. U. S. A. 98, 11042-11046
38. Nestler, E. J. (1997) Molecular mechanisms of opiate and cocaine addiction. Curr. Opin. Neurobiol. 7, 713-719
39. Ghisi, V., Ramsey, A. J., Masri, B., Gainetdinov, R. R., Caron, M. G., and Salahpour, A. (2009) Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cell. Signal. 21, 87-94
40. Cabib, S., Puglisi-Allegra, S., Genua, C., Simon, H., Le Moal, M., and Piazza, P. V. (1996) Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus. Psychopharmacology (Berl.) 125, 92-96
41. McGinty, J. F., Shi, X. D., Schwendt, M., Saylor, A., and Toda, S. (2008) Regulation of psychostimulant-induced signaling and gene expression in the striatum. J. Neurochem. 104, 1440-1449 (Pubitemid 351316778)
42. Borgkvist, A., Usiello, A., Greengard, P., and Fisone, G. (2007) Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology 32, 1995-2003 (Pubitemid 47258515)
43. Jenab, S., Festa, E. D., Nazarian, A., Wu, H. B., Sun, W. L., Hazim, R., Russo, S. J., and Quinones-Jenab, V. (2005) Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. Brain Res. Mol. Brain Res. 142, 134-138 (Pubitemid 41681280)
44. Valjent, E., Corvol, J. C., Pages, C., Besson, M. J., Maldonado, R., and Caboche, J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701-8709
45. Moratalla, R., Elibol, B., Vallejo, M., and Graybiel, A. M. (1996) Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17, 147-156
46. Sora, I., Hall, F. S., Andrews, A. M., Itokawa, M., Li, X. F., Wei, H. B., Wichems, C., Lesch, K. P., Murphy, D. L., and Uhl, G. R. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl. Acad. Sci. U. S. A. 98, 5300-5305
47. Schechter, M. D., and Calcagnetti, D. J. (1993) Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci. Biobehav. Rev. 17, 21-41 (Pubitemid 23068940)
48. Beaulieu, J. M., Sotnikova, T. D., Gainetdinov, R. R., and Caron, M. G. (2006) Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J. Biol. Chem. 281, 32072-32080
49. Imai, Y., Inoue, H., Kataoka, A., Hua-Qin, W., Masuda, M., Ikeda, T., Tsukita, K., Soda, M., Kodama, T., Fuwa, T., Honda, Y., Kaneko, S., Matsumoto, S., Wakamatsu, K., Ito, S., Miura, M., Aosaki, T., Itohara, S., and Takahashi, R. (2007) Pael receptor is involved in dopamine metabolism in the nigrostriatal system. Neurosci. Res. 59, 413-425 (Pubitemid 350007809)
50. Surmeier, D. J., Ding, J., Day, M., Wang, Z., and Shen, W. (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30, 228-235
51. Girault, J. A., Valjent, E., Caboche, J., and Herve, D. (2007) ERK2: a logical and gate critical for drug-induced plasticity? Curr. Opin. Pharmacol. 7, 77-85
52. Sora, I., Wichems, C., Takahashi, N., Li, X. F., Zeng, Z., Revay, R., Lesch, K. P., Murphy, D. L., and Uhl, G. R. (1998) Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. U. S. A. 95, 7699-7704
53. Choe, E. S., Chung, K. T., Mao, L., and Wang, J. Q. (2002) Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27, 565-575
54. Budygin, E. A., Brodie, M. S., Sotnikova, T. D., Mateo, Y., John, C. E., Cyr, M., Gainetdinov, R. R., and Jones, S. R. (2004) Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proc. Natl. Acad. Sci. U. S. A. 101, 7781-7786
55. Mateo, Y., Budygin, E. A., John, C. E., and Jones, S. R. (2004) Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc. Natl. Acad. Sci. U. S. A. 101, 372-377
56. Medvedev, I. O., Gainetdinov, R. R., Sotnikova, T. D., Bohn, L. M., Caron, M. G., and Dykstra, L. A. (2005) Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice. Psychopharmacology (Berl.) 180, 408-413
57. Hall, F. S., Li, X. F., Randall-Thompson, J., Sora, I., Murphy, D. L., Lesch, K. P., Caron, M., and Uhl, G. R. (2009) Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 162, 870-880
58. McClung, C. A., Ulery, P. G., Perrotti, L. I., Zachariou, V., Berton, O., and Nestler, E. J. (2004) DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res. Mol. Brain Res. 132, 146-154 (Pubitemid 39586757)
59. Pavon, N., Martin, A. B., Mendialdua, A., and Moratalla, R. (2006) ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol. Psychiatry 59, 64-74 (Pubitemid 43005237)
60. Usiello, A., Baik, J. H., Rouge-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., and Borrelli, E. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408, 199-203
61. Dunham, J. H., Meyer, R. C., Garcia, E. L., and Hall, R. A. (2009) GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. Biochemistry 48, 10286-10297
62. Sotnikova, T. D., Beaulieu, J. M., Espinoza, S., Masri, B., Zhang, X., Salahpour, A., Barak, L. S., Caron, M. G., and Gainetdinov, R. R. The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS ONE 5, e13452
63. Xie, Z., and Miller, G. M. (2009) Trace amine-associated receptor 1 as a monoaminergic modulator in brain. Biochem. Pharmacol. 78, 1095-1104